Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitative Evaluation of a Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Individuals With Symptoms or Clinical Findings Suspicious for Bladder Cancer

NCT02538809 is registered in ClinicalTrials.gov with Swiss Paraplegic Research, Nottwil as lead sponsor.

NCT NCT02538809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02538809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitative Evaluation of a Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Individuals With Symptoms or Clinical Findings Suspicious for Bladder Cancer
Lead sponsor
Swiss Paraplegic Research, Nottwil
Phase
Observational
Overall status
Terminated
Start date
August 13, 2018
Completion date
December 31, 2024
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, spinal cord injury